Livzon Pharma Jumps Over 10% in Morning Session on Generous Dividend Payout and Three-Year Shareholder Return Plan

Deep News
10/26

Livzon Pharma (01513) surged more than 10% in morning trading, with shares up 10.63% as of press time to HK$22.90, on turnover of HK$71.81 million.

The company announced a plan to distribute a cash dividend of RMB 12.39 per 10 shares (tax inclusive) to all shareholders, with total cash dividends expected to reach RMB 1.10 billion.

Notably, the company has also formulated a "Three-Year (2026–2028) Shareholder Return Plan," which specifies that, provided conditions for cash dividends are met, the total annual cash dividend payout shall in principle be no less than 90% of the distributable profit realized in that year, and the aggregate annual cash dividend amount shall in principle be no less than RMB 2 billion (tax inclusive).

Livzon Pharma's third-quarter report shows that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year-on-year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year-on-year. For the third quarter alone, main operating revenue was RMB 2.32 billion, down 18.44% year-on-year; net profit attributable to shareholders for the quarter was RMB 356 million, down 24.76% year-on-year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10